Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer.
暂无分享,去创建一个
[1] K. Pearson. Biometrika , 1902, The American Naturalist.
[2] R. Fisher. FREQUENCY DISTRIBUTION OF THE VALUES OF THE CORRELATION COEFFIENTS IN SAMPLES FROM AN INDEFINITELY LARGE POPU;ATION , 1915 .
[3] G. Hughes,et al. Number of pattern classifier design samples per class (Corresp.) , 1969, IEEE Trans. Inf. Theory.
[4] Anil K. Jain,et al. On the optimal number of features in the classification of multivariate Gaussian data , 1978, Pattern Recognit..
[5] Leslie G. Valiant,et al. A theory of the learnable , 1984, STOC '84.
[6] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[7] 김삼묘,et al. “Bioinformatics” 특집을 내면서 , 2000 .
[8] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[10] E. Lander,et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Spang,et al. Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] David E. Misek,et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.
[13] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[14] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[15] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[16] J. Downing,et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.
[17] N. Iizuka,et al. MECHANISMS OF DISEASE Mechanisms of disease , 2022 .
[18] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[19] G. Nemes. Asymptotic Expansions of Integrals , 2004 .
[20] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[21] J. Brenton,et al. Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt , 2005, Breast Cancer Research.
[22] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[23] C. Caldas,et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Eytan Domany,et al. Outcome Signature Genes in Breast Cancer: Is There a Unique Set? , 2022 .
[25] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[26] J. Ioannidis. Microarrays and molecular research: noise discovery? , 2005, The Lancet.
[27] T. Sørlie,et al. Genomics in breast cancer—therapeutic implications , 2005, Nature Clinical Practice Oncology.
[28] Y. Oshika,et al. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.